Primary Site >> Colorectal Cancer

Gene >> PTGER1

  • 1992
  • 1993
  • 1994
  • 1999
  • 2000
  • 2001
  • 2002
  • 2005
  • 2006
  • 2007
  • 2008
  • 2010
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
Ref: Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
PMID: 1476671
Ref: The tyrosine residue at position 97 in the VH CDR3 region of a mouse/human chimeric anti-colorectal carcinoma antibody contributes hydrogen bonding to the TAG72 antigen.
PMID: 7804366
Ref: Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
PMID: 7756575
Ref: Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
PMID: 10537280
Ref: Effect of prostaglandin E(2) on the proliferation, Ca(2+) mobilization and cAMP in HT-29 human colon adenocarcinoma cells.
PMID: 10773415
Ref: COX-2 and iNOS, good targets for chemoprevention of colon cancer.
PMID: 11216473
Ref: Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
PMID: 11533709
Ref: Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis.
PMID: 11911260
Ref: COX-2 and prostanoid receptors: good targets for chemoprevention.
PMID: 12086401
Ref: Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues.
PMID: 15637741
Ref: Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.
PMID: 15904466
Ref: Prospects in NSAID-derived chemoprevention of colorectal cancer.
PMID: 16042570
Ref: Roles of prostanoids in colon carcinogenesis and their potential targeting for cancer chemoprevention.
PMID: 16842185
Ref: Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
PMID: 16859832
Ref: EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
PMID: 17290397
Ref: Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells.
PMID: 17555711
Ref: The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.
PMID: 17631291
Ref: Prostanoid receptor EP1 expression in breast cancer.
PMID: 17906615
Ref: Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice.
PMID: 18485889
Ref: Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.
PMID: 18648368
Ref: Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells.
PMID: 19055708
Ref: Receptor and enzyme expression for prostanoid metabolism in colorectal cancer related to tumor tissue PGE2.
PMID: 20043083
Ref: Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
PMID: 20100359
Ref: EP4 upregulation of Ras signaling and feedback regulation of Ras in human colon tissues and cancer cells.
PMID: 20571779
Ref: The induction of S100p expression by the Prostaglandin E(2) (PGE(2))/EP4 receptor signaling pathway in colon cancer cells.
PMID: 20890108
Ref: ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression.
PMID: 21937683
Ref: Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.
PMID: 23390011
Ref: Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
PMID: 23567332
Ref: Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells.
PMID: 25096910
Ref: Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo.
PMID: 25139833
Ref: Definition of Prostaglandin E2-EP2 Signals in the Colon Tumor Microenvironment That Amplify Inflammation and Tumor Growth.
PMID: 26018088
Ref: Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancer.
PMID: 26269760
Ref: Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.
PMID: 26211005
Ref: Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.
PMID: 26300003
Ref: The Roles of EP4 Prostanoid Receptors in Cancer Malignancy Signaling.
PMID: 26830476
Ref: Cytotoxic and pro-oxidative effects of Imperata cylindrica aerial part ethyl acetate extract in colorectal cancer in vitro.
PMID: 27064015
Ref: High HSF4 expression is an independent indicator of poor overall survival and recurrence free survival in patients with primary colorectal cancer.
PMID: 29131521